GeneHealth - Your precision medicine

Cyclosporiasis

Disease Details

Family Health Simplified

Buy Membership

Description: Cyclosporiasis is an intestinal infection caused by the protozoan parasite Cyclospora cayetanensis, typically resulting in watery diarrhea, abdominal cramping, and other gastrointestinal symptoms.
Type: Cyclosporiasis is an infection caused by the protozoan parasite Cyclospora cayetanensis. It is not genetically transmitted; rather, it spreads through ingestion of food or water contaminated with feces that contain the parasite.
Signs And Symptoms: **Signs and Symptoms of Cyclosporiasis:**
- Watery diarrhea
- Loss of appetite
- Weight loss
- Cramping
- Bloating
- Increased gas
- Nausea
- Fatigue
- Low-grade fever
- Vomiting (less common)

These symptoms can persist for several weeks and may relapse if not treated.
Prognosis: The prognosis for cyclosporiasis is generally good, especially with prompt treatment. Most individuals recover fully with the appropriate use of antibiotics, typically trimethoprim-sulfamethoxazole (TMP-SMX). In some cases, especially in those with weakened immune systems, the infection might be more severe and require longer treatment. Proper hygiene and food safety practices can prevent re-infection.
Onset: Cyclosporiasis typically has an onset of about 2 to 14 days after ingestion of the parasite Cyclospora cayetanensis. Symptoms can include watery diarrhea, loss of appetite, weight loss, cramping, bloating, increased gas, nausea, and fatigue.
Prevalence: Cyclosporiasis is a parasitic infection caused by the protozoan Cyclospora cayetanensis. The prevalence of cyclosporiasis varies by region. It is more common in tropical and subtropical areas, where sanitation and water treatment may be less reliable. Outbreaks are often linked to the consumption of contaminated food and water, especially fresh produce like berries, basil, and lettuce. In the United States, the prevalence is relatively low but there have been sporadic outbreaks, typically during the summer months. Detection and reporting practices may also influence observed prevalence rates.
Epidemiology: The first recorded cases of cyclosporiasis in humans were as recent as 1977, 1978, and 1979. They were reported by Ashford, a British parasitologist who discovered three cases while working in Papua New Guinea. Ashford found that the parasite had very late sporulation, from 8–11 days, making the illness difficult to diagnose. When examining feces, the unsporulated oocysts can easily be mistaken for fungal spores, and thus can be easily overlooked.In 2007, Indian researchers published a case report that found an association between Cyclospora infection and Bell's palsy. This was the first reported case of Bell's palsy following chronic Cyclospora infection. In addition to other extra-intestinal reports, cyclosporiasis might be involved in either reversible neuronal damage or other unknown mechanisms to lead to Guillain-Barré syndrome or Bell's palsy.
In 2010, a report of Cyclospora transmission via swimming in the Kathmandu Valley was published in the Journal of Institute of Medicine. The researchers found that openly defecated human stool samples around the swimmer's living quarters and near the swimming pool were positive for Cyclospora. However, they did not find the parasite in dog stool, bird stool, cattle dung, vegetable samples, or water samples. They concluded that pool water contaminated via environmental pollution might have caused the infection, as the parasite can resist chlorination in water.Cyclosporiasis infections have been well reported in Nepal. In one study, Tirth Raj Ghimire, Purna Nath Mishra, and Jeevan Bahadur Sherchan collected samples of vegetables, sewage, and water from ponds, rivers, wells, and municipal taps in the Kathmandu Valley from 2002 to 2004. They found Cyclospora in radish, cauliflower, cabbage, and mustard leaves, as well as sewage and river water. This first epidemiological study determined the seasonal character of cyclosporiasis outbreaks in Nepal during the rainy season, from May to September.
Intractability: Cyclosporiasis is not generally considered intractable. It is an infection caused by the parasite Cyclospora cayetanensis, and it is typically treated with a combination of antibiotics, specifically trimethoprim-sulfamethoxazole (TMP-SMX). Most patients respond well to this treatment. However, if untreated, the symptoms can persist and lead to prolonged illness.
Disease Severity: Cyclosporiasis is generally considered a gastrointestinal illness caused by the parasite Cyclospora cayetanensis. The disease severity can vary; for most healthy individuals, it causes moderate to severe symptoms, such as prolonged watery diarrhea, stomach cramps, bloating, nausea, and fatigue. In immunocompromised individuals or those with underlying health issues, the severity can escalate, potentially leading to significant dehydration and other complications.
Healthcare Professionals: Disease Ontology ID - DOID:12750
Pathophysiology: Cyclosporiasis is an intestinal infection caused by the parasite Cyclospora cayetanensis. The pathophysiology involves ingestion of food or water contaminated with oocysts, which are the infective form of the parasite. Once inside the human host, the oocysts release sporozoites in the small intestine. These sporozoites invade the epithelial cells of the intestinal mucosa, where they undergo asexual and sexual reproduction, leading to the formation of new oocysts. This cycle can cause inflammation and disruption of the intestinal epithelium, resulting in symptoms such as prolonged watery diarrhea, abdominal cramps, bloating, nausea, and fatigue. The oocysts are then excreted in the feces, potentially contaminating further food or water sources.
Carrier Status: Cyclosporiasis:
- **Carrier Status**: There are no chronic carriers for cyclosporiasis. The infection is typically acquired by consuming contaminated food or water, and the parasite Cyclospora cayetanensis must complete its lifecycle outside the human body.
- **Nan**: Not applicable or not relevant in the context of cyclosporiasis.
Mechanism: Cyclosporiasis is an intestinal infection caused by the parasite *Cyclospora cayetanensis*.

Mechanism:
1. **Transmission and Infection:** The disease is transmitted through ingestion of food or water contaminated with *Cyclospora* oocysts. Once ingested, these oocysts excyst in the small intestine, releasing sporozoites.
2. **Invasion and Reproduction:** The sporozoites invade the epithelial cells of the small intestine, where they undergo asexual and sexual reproduction.
3. **Symptoms:** The resulting damage to the intestinal lining disrupts absorption and can cause symptoms such as watery diarrhea, abdominal cramps, nausea, and vomiting.

Molecular Mechanisms:
1. **Host-Pathogen Interaction:** *Cyclospora cayetanensis* interacts with host intestinal epithelial cells using surface proteins that facilitate attachment and invasion. The exact molecular mechanisms of this interaction are not fully elucidated but involve a range of host cell receptors and parasite ligands.
2. **Immune Evasion:** The parasite modulates the host's immune response to evade detection and destruction. This may involve altering antigenic expression and manipulating host immune pathways.
3. **Cellular Damage:** The reproduction of the parasite within host cells leads to cell lysis and intestinal mucosa damage, contributing to malabsorption and inflammatory responses.

Understanding the detailed molecular mechanisms of *Cyclospora cayetanensis* is an ongoing area of research, aiming to develop better diagnostic, preventative, and therapeutic measures.
Treatment: The infection is often treated with trimethoprim/sulfamethoxazole, also known as Bactrim or co-trimoxazole, because traditional anti-protozoal drugs are not sufficient. To prevent transmission, food should be cooked thoroughly and drinking water from streams should be avoided.
Compassionate Use Treatment: For cyclosporiasis, the standard treatment is typically a course of the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX), known commercially as Bactrim, Septra, or Cotrim. Compassionate use, off-label, or experimental treatments are generally considered when standard treatments are ineffective, contraindicated, or not tolerated. Potential alternatives may include:

1. **Nitazoxanide**: Though primarily used for other parasitic infections, it has shown some effectiveness against Cyclospora cayetanensis in certain cases.
2. **Ciprofloxacin**: This antibiotic has been used off-label in some cases, though its efficacy is not as well established as TMP-SMX.
3. **Rifaximin**: Another antibiotic that may be considered, especially in regions where resistance to TMP-SMX is problematic.

These alternatives are usually considered on a case-by-case basis and generally under specialist guidance.
Lifestyle Recommendations: Here are some lifestyle recommendations for cyclosporiasis:

1. **Personal Hygiene:** Wash hands thoroughly with soap and water before eating, preparing food, and after using the bathroom.
2. **Food and Water Safety:** Avoid consuming untreated water and ensure food (especially fruits and vegetables) is washed thoroughly or cooked. Avoid raw produce in areas where cyclosporiasis is common.
3. **Travel Precautions:** When traveling to areas with known outbreaks, drink bottled or boiled water, and avoid street food or raw foods.
4. **Sanitary Practices:** Clean and sanitize kitchen surfaces and utensils, and ensure proper sanitation to prevent contamination.
5. **Avoid Cross-Contamination:** Separate raw and cooked foods to prevent the spread of pathogens.

Implementing these practices can help reduce the risk of contracting cyclosporiasis.
Medication: Cyclosporiasis is an intestinal infection caused by the parasite Cyclospora cayetanensis. The recommended medication for treating cyclosporiasis is trimethoprim-sulfamethoxazole (TMP-SMX). The standard adult dosage is one double-strength tablet (160 mg trimethoprim and 800 mg sulfamethoxazole) taken twice a day for 7 to 10 days. For individuals who are unable to take TMP-SMX, there are no highly effective alternative treatments, but consultation with a healthcare provider is necessary for managing the infection.
Repurposable Drugs: Cyclosporiasis is caused by the parasite Cyclospora cayetanensis. Treatment typically involves the use of the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX). Repurposing other drugs for cyclosporiasis is an area of ongoing research, but no other specific repurposed drugs are widely recognized or established for treating this infection as of now.

"nan" could stand for "not applicable" or "not available." If you are looking for additional specific information, please clarify.
Metabolites: Cyclosporiasis is an intestinal infection caused by the parasite Cyclospora cayetanensis. Specific metabolites for this condition are not typically a focus of diagnosis or treatment. Instead, diagnosis is usually made through stool exams to identify the parasite, and treatment generally involves antibiotics like trimethoprim-sulfamethoxazole (TMP-SMX). If you are inquiring about a particular aspect related to metabolites, more context might help provide a more specific answer.
Nutraceuticals: There is no established evidence that nutraceuticals are effective in treating or preventing cyclosporiasis. The infection is typically treated with prescribed antibiotics such as trimethoprim-sulfamethoxazole. Maintaining good hygiene and properly washing produce are key preventive measures. Nanotechnology-related approaches are still largely experimental and have not been established as a treatment for cyclosporiasis.
Peptides: Cyclosporiasis is caused by the parasitic protozoan Cyclospora cayetanensis. It is not directly related to peptides or nanoparticles (nan). The parasite infects the small intestine, leading to gastrointestinal symptoms such as diarrhea. The disease is primarily transmitted through ingestion of contaminated food or water. Effective treatment typically involves antimicrobial therapy, specifically with medications like trimethoprim-sulfamethoxazole. Preventative measures focus on proper sanitation and safe food handling practices.